| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Hijack of ubiquitination by sarscov2 0.8818447266716034 2.9206037208464304 0.003493538858482 0.8792208890799871 0.5772032104818338 6 Q8TBC4,Q13951,Q15370 3 |
| Serotonin htr1 group and fos pathway 0.8226521380312697 2.6560851451343264 0.0079053651597942 0.991719186334817 0.5772032104818338 7 P28482,P08754 2 |
| Resistin as a regulator of inflammation 0.7930461831179036 2.5624395318333724 0.0103939685347023 0.9981834411233482 0.5772032104818338 6 P28482,P31751 2 |
| Serine metabolism 0.7917703877982168 2.5571612572774898 0.0105530283928398 0.9983515178291232 0.5772032104818338 6 P00374,Q9Y617,P34896,P78330 4 |
| Kisspeptinkisspeptin receptor system in the ovary 0.7766190770488892 2.4941813068452223 0.0126248039598837 0.9995352100924922 0.5772032104818338 6 P31751 1 |
| Physiological and pathological hypertrophy of the heart 0.7666346171023236 2.4523789551593542 0.0141915117291948 0.9998218843004398 0.5772032104818338 6 P28482,Q08209,P61586 3 |
| Transsulfuration pathway 0.7655815925089242 2.44795625696587 0.0143669096658203 0.999840034474832 0.5772032104818338 6 Q9NZL9,P23526 2 |
| Osteopontin signaling 0.7648211587944611 2.444760779075917 0.0144948248855665 0.9998520955782596 0.5772032104818338 6 P28482 1 |
| Disruption of postsynaptic signaling by cnv 0.7677199536711717 2.401257729821865 0.0163388242626654 0.9999522800016472 0.5772032104818338 8 P28482,Q06787,Q14168 3 |
| Relationship between inflammation cox2 and egfr 0.7451765734364268 2.3617262511569086 0.0181900685774647 0.9999847045521212 0.5772032104818338 6 P31751 1 |
| Estrogen signaling pathway 0.7347936864305328 2.3174606547100867 0.020478651552795 0.9999962640668734 0.5772032104818338 6 P28482 1 |
| Autophagy 0.7292655323562838 2.293784935187889 0.0218028551730666 0.9999983497867058 0.5772032104818338 6 Q9Y4P8 1 |
| Pathogenic escherichia coli infection 0.8455076529391151 2.286510974015296 0.0222243828617378 0.9999987280248408 0.5772032104818338 25 P07437,P68371,P04350,Q9BVA1,Q13885,Q9BUF5 6 |
| Interleukin1 il1 structural pathway 0.7526278594040007 2.282788606104041 0.0224428234416182 0.9999988886018036 0.5772032104818338 10 Q15750,O14920,P28482,P06730 4 |
| Biotin metabolism including iems 0.7243302288591897 2.21672696197955 0.0266417551826281 0.9999999174498252 0.5772032104818338 8 P50747,O00763,P05165,Q13085,Q96RQ3 5 |
| Ethanol effects on histone modifications 0.7343193922093396 2.204759690717605 0.0274709620186441 0.999999950664813 0.5772032104818338 10 P00374 1 |
| Methionine de novo and salvage pathway 0.7265685447254326 2.1988020487705375 0.0278920007694054 0.9999999620188444 0.5772032104818338 9 P52788,Q13126,P23526 3 |
| Osteoblast differentiation and related diseases 0.7100270936107274 2.1827351359510323 0.0290553208484487 0.9999999815723644 0.5772032104818338 7 P28482,P35222 2 |
| Neurodegeneration with brain iron accumulation nbia subtypes pathway 0.7225812550040802 2.1543263611286245 0.031214586982867 0.9999999951975264 0.5772032104818338 10 Q96B36,P49815,Q9Y4P8 3 |
| Follicle stimulating hormone fsh signaling pathway 0.7001145539257527 2.1396185815470874 0.032385603700388 0.9999999976868594 0.5772032104818338 7 P28482,P49815 2 |
| Nucleotide metabolism 0.7123511700665464 2.0562214617663925 0.0397611745010846 0.9999999999772452 0.6169763418341025 12 P00374,P22392,P30520,P23921,P28340 5 |
| Cytosine methylation 0.9061455202915064 2.023494302759976 0.0430222103758279 0.9999999999970844 0.6169763418341025 5 P48735 1 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.6835985191857652 2.011871650740815 0.04423346849785 0.9999999999986432 0.6169763418341025 9 P28482,P31751 2 |
| Onecarbon metabolism 0.7065507467114429 2.00447515283126 0.0450191859611912 0.9999999999991744 0.6169763418341025 13 P00374,P34896,P23526 3 |
| Parkinubiquitin proteasomal system pathway 0.8264047860890275 2.0010004080854267 0.0453923459135134 0.999999999999348 0.6169763418341025 34 P07437,P68371,P04350,Q9BVA1,Q13885 5 |
| Type ii diabetes mellitus 0.6487479776833388 1.9404560194094391 0.0523242941971782 0.999999999999992 0.6345747683632861 6 P28482 1 |
| Ebsteinbarr virus lmp1 signaling 0.8812761157919841 1.928057411800464 0.0538479854730793 0.999999999999997 0.6345747683632861 5 P28482,Q9NR12 2 |
| Aryl hydrocarbon receptor pathway wp2873 0.6318299285523694 1.864217072610206 0.0622912267906203 1.0 0.6569046926639724 6 Q15185 1 |
| Cardiac hypertrophic response 0.6667041121190436 1.8561758652351452 0.0634284949867045 1.0 0.6569046926639724 12 P28482,Q08209,O14920,P31751 4 |
| Transsulfuration and onecarbon metabolism 0.6892932763142048 1.8510118906495807 0.0641678424953218 1.0 0.6569046926639724 16 O43175,P00374,P78330,P23526,P34896,Q9Y617,Q9NZL9 7 |
| Il9 signaling pathway 0.6266648579696495 1.8128250379017377 0.0698588109341256 1.0 0.6778646036324419 7 P28482,P40763 2 |
| Nongenomic actions of 125 dihydroxyvitamin d3 0.6324765603783278 1.811422635710924 0.0700754546908291 1.0 0.6778646036324419 8 P28482,O14920 2 |
| Inhibition of exosome biogenesis and secretion by manumycin a in crpc cells 0.6269988133141405 1.7866419221682373 0.0739953814528795 1.0 0.6778646036324419 8 P28482,P61020 2 |
| Mirna regulation of prostate cancer signaling pathways 0.6202760458671963 1.7838081247892277 0.0744548489059648 1.0 0.6778646036324419 7 P28482,P35222 2 |
| H19 action rbe2f1 signaling and cdkbetacatenin activity 0.6031068239980306 1.7332590433632655 0.0830496368688753 1.0 0.6778646036324419 6 Q16527,P35222 2 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.6020182605005726 1.700392319201909 0.0890571556039101 1.0 0.7077700261152858 7 P28482 1 |
| Thyroid hormones production and peripheral downstream signaling effects 0.6423099296553217 1.6691259655247912 0.0950924183955801 1.0 0.7079845820438582 15 Q96B36,P49815,P28482,P62753,P35222 5 |
| Development of ureteric collection system 0.5877545129019593 1.6625124587755007 0.0964100674025605 1.0 0.7079845820438582 6 Q13418,Q12948,P35222 3 |
| Il2 signaling pathway 0.6149064759848188 1.6505146161455246 0.098837726383306 1.0 0.7079845820438582 11 P22681,P40763,P62753,P28482 4 |
| Pdgfrbeta pathway 0.587313460075479 1.6327002601433174 0.1025320527073145 1.0 0.7079845820438582 7 P19525,P45985,P40763,P62993 4 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.6106588924282538 1.6312261301758837 0.1028426136344973 1.0 0.7079845820438582 11 P28482,O14920,P31751 3 |
| Intraflagellar transport proteins binding to dynein 0.5801347913725965 1.6272153376829597 0.1036913713643934 1.0 0.7079845820438582 6 P63167,Q9BW83 2 |
| Epo receptor signaling 0.5843014025720429 1.6187810009980594 0.105494391364151 1.0 0.7079845820438582 7 P28482,P40763 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.5791770111088606 1.5950598605319226 0.1106988503685051 1.0 0.7175788931073781 7 P28482,P24941 2 |
| Embryonic stem cell pluripotency pathways 0.6070822448163467 1.5885251070784747 0.1121676483108173 1.0 0.7175788931073781 12 P31751,P28482,P35222,P40763,P62993 5 |
| Tcell activation sarscov2 0.6061145417747811 1.5841279022300738 0.1131646159743682 1.0 0.7175788931073781 12 P28482,O14920,P49815,Q07812 4 |
| Il4 signaling pathway 0.5952547570708567 1.5610118039791463 0.1185209657910864 1.0 0.7175788931073781 11 P22681,P40763,O14920,P28482 4 |
| Endometrial cancer 0.6065238717310036 1.5598455483214142 0.1187963847720534 1.0 0.7175788931073781 13 Q07812,P31751,P28482,P35222,Q13418 5 |
| Wnt signaling 0.6055436461700734 1.5553990190014035 0.1198510676127306 1.0 0.7175788931073781 13 P35222,Q08209,P61586,Q13555 4 |
| Mapk cascade 0.7845601619895416 1.5499157060010913 0.1211617494030172 1.0 0.7175788931073781 5 P28482,P45985 2 |
| 16p112 distal deletion syndrome 0.5606046881531408 1.5362218913909944 0.1244839686972738 1.0 0.7175788931073781 6 Q99873,P62993 2 |
| Onecarbon metabolism and related pathways 0.5867402296215197 1.522034228445692 0.1280005044347922 1.0 0.7293613648925898 11 O15382,P35790,P34896,P54687 4 |
| Micrornas in cardiomyocyte hypertrophy 0.6355695460342633 1.5139499682572586 0.1300385293874475 1.0 0.7340492686917599 20 P45985,O14920,P61586,Q15750,P31751,P28482,Q08209,P35222 8 |
| Ranklrank signaling pathway 0.6089990121836214 1.494278577402224 0.1351028220040098 1.0 0.7363738399891752 16 P22681,O14920,P31751,P28482,Q15750 5 |
| Pyrimidine metabolism and related diseases 0.7697191585339531 1.491113141062398 0.135931792765731 1.0 0.7363738399891752 5 P23921,P11172 2 |
| Type 2 papillary renal cell carcinoma 0.5611380126086988 1.48394819990195 0.1378226633370887 1.0 0.7363738399891752 8 Q15369,Q15370 2 |
| Energy metabolism 0.5643478296493966 1.4719462248789443 0.1410353996108484 1.0 0.7363738399891752 9 Q99873,Q08209,Q13555 3 |
| Purine metabolism and related disorders 0.5825704126724552 1.4507965085864312 0.1468365321712594 1.0 0.7363738399891752 13 P22234,P31153,O15067,Q06203,P30520,Q9BY32,P07741,P00491 8 |
| Cysteine and methionine catabolism 0.7591840732607549 1.4492888343759789 0.1472569379402966 1.0 0.7363738399891752 5 P23526 1 |
| Histone modifications 0.5871415504245808 1.4460092667597082 0.1481746026830652 1.0 0.7363738399891752 14 Q9H7B4 1 |
| Fluoropyrimidine activity 0.5697644925622769 1.444004312099736 0.1487377623819195 1.0 0.7363738399891752 11 P00374,P04183,Q06203,P23921,P11172 5 |
| Photodynamic therapyinduced ap1 survival signaling 0.5476137998415657 1.4208524417644883 0.1553596613355923 1.0 0.7567518987636916 8 P20248,Q07812 2 |
| Il7 signaling pathway 0.5318659459644598 1.4011055267723762 0.1611825191525955 1.0 0.758862397123145 6 P28482 1 |
| Target of rapamycin tor signaling 0.5544444189891196 1.3994396853331206 0.1616811732762719 1.0 0.758862397123145 10 P49815,Q9HB90 2 |
| Biomarkers for pyrimidine metabolism disorders 0.7441188701956829 1.3893888802140393 0.1647145297969825 1.0 0.7652890461336728 5 P23921,Q9Y606,P11172 3 |
| Serotonin and anxiety 0.938648293963255 1.3642818508020131 0.1724788757463282 1.0 0.7832875259457314 2 Q08209 1 |
| Tca cycle and deficiency of pyruvate dehydrogenase complex pdhc 0.5667412817106752 1.3278677200138655 0.1842218102868202 1.0 0.7878673495605835 15 O75874,P08559,P11498,P53396 4 |
| Interferon type i signaling pathways 0.5663048652247438 1.3258794510176235 0.1848796305282674 1.0 0.7878673495605835 15 P22681,Q06124,P60842,Q53EL6,P06730,Q99873,P62753,P42224,P40763,P63244 10 |
| Hereditary leiomyomatosis and renal cell carcinoma pathway 0.5412285165671848 1.312059704029941 0.1894999907433765 1.0 0.7878673495605835 11 P62753,Q13085,O00763 3 |
| Purine metabolism 0.5218954215477883 1.300231632585851 0.1935215920234281 1.0 0.7878673495605835 8 P07741,P00491,P30520,Q9BY32 4 |
| Lipid metabolism pathway 0.5331098874351499 1.3002255447384914 0.1935236779350821 1.0 0.7878673495605835 10 Q13085,P31751 2 |
| Glycolysis in senescence 0.5267673458999578 1.296722226127298 0.1947267790388525 1.0 0.7878673495605835 9 P09972,P06733,P14618,P11413,P00558,P00338 6 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.5475588542910049 1.2902414535707794 0.1969668373901458 1.0 0.7878673495605835 13 P55884,Q13347,O15371,P60228,P05198,O75822 6 |
| Genes controlling nephrogenesis 0.5245600938840512 1.2863868218768877 0.1983080952293918 1.0 0.7880137468325834 9 P16333,Q96J84,Q12948,P35222 4 |
| Ampactivated protein kinase ampk signaling 0.5610227815069962 1.2771253968834693 0.201557979890536 1.0 0.7916015452584022 16 P20248,P49815,O00763,P31751 4 |
| Physicochemical features and toxicityassociated pathways 0.5747554858118256 1.2428981488529842 0.2139053679416593 1.0 0.8049868600652743 20 P22681,P45985,P61586,P28482,P35080,P35222,P16333,P07737,P62993 9 |
| Mesodermal commitment pathway 0.5794960491836305 1.2406146408212242 0.2147481407710991 1.0 0.8049868600652743 21 Q12948,P42858,Q13085,O95071,Q16527 5 |
| Il1 signaling pathway 0.5402934992454577 1.2318566699418991 0.2180026297942281 1.0 0.8078134257405755 14 Q15750,O14920,P28482,Q13501 4 |
| Nonsmall cell lung cancer 0.5368969699827737 1.2162873312505715 0.2238754858164382 1.0 0.8245170331288335 14 Q07812,P11802,P31751,P28482,P40763 5 |
| Wnt signaling in kidney disease 0.9009186351706046 1.2049441030114976 0.2282248813216107 1.0 0.8255983533891028 2 P35222 1 |
| Il6 signaling pathway 0.5235808742524827 1.2048279092166136 0.2282697434039406 1.0 0.8255983533891028 12 P28482,P45985,P40763 3 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.904479925275542 1.189589632437881 0.2342077227064303 1.0 0.8420325268731186 4 P55263,P23526 2 |
| Splicing factor nova regulated synaptic proteins 0.5353943762364184 1.1848720764033 0.2360680293801391 1.0 0.8425568856258967 15 Q9UNS2,Q12955,Q9UBB6,Q9NQX3,P11171 5 |
| Urea cycle and metabolism of amino groups 0.4906255571518079 1.178951489375813 0.2384174931047766 1.0 0.8425568856258967 7 P52788,P00367,P19623 3 |
| Signal transduction through il1r 0.679737004076771 1.1332503986199065 0.2571091150358646 1.0 0.8823517356912628 5 Q15750 1 |
| Bladder cancer 0.676474203641968 1.1203143308163162 0.2625798372655255 1.0 0.8900265441349325 5 P28482 1 |
| Il17 signaling pathway 0.674143903220898 1.1110810629898695 0.2665334582792116 1.0 0.8900265441349325 5 P28482,O14920 2 |
| Aerobic glycolysis 0.4944038920166338 1.094582572905053 0.2736995538616149 1.0 0.892369200932502 11 P04075,P60174,P06733,P14618,P00558,P08237,P04406,P00338 8 |
| Il3 signaling pathway 0.504717071276224 1.093064921065712 0.274365296420956 1.0 0.892369200932502 13 P22681,P40763,P28482 3 |
| Head and neck squamous cell carcinoma 0.5133108524293726 1.0841913947055384 0.2782799463173724 1.0 0.892369200932502 15 P49815,P31751,P06730,P62753,P35222 5 |
| Map3k1 role in promoting and blocking gonadal determination 0.9012143091565504 1.077638223635549 0.2811952371958495 1.0 0.892369200932502 3 P28482,P35222 2 |
| Metapathway biotransformation phase i and ii 0.5420662029619606 1.0742407691466094 0.2827147842423494 1.0 0.892369200932502 21 P34913,O15217,P21266,O43488 4 |
| Wnt signaling pathway 0.494952809011093 1.0724907657738951 0.2834996593648955 1.0 0.892369200932502 12 P28482,P49815,P35222,P61586 4 |
| Mapk and nfkb signaling pathways inhibited by yersinia yopj 0.8997539634168095 1.0722741546770338 0.2835969118117316 1.0 0.892369200932502 3 P28482 1 |
| Vitamin d in inflammatory diseases 0.8976724978842556 1.064634978546669 0.2870411445845655 1.0 0.892369200932502 3 Q08209 1 |
| Folate metabolism 0.5061284307905423 1.0515234640768996 0.2930182385777709 1.0 0.892369200932502 15 P00374,P34896 2 |
| Erbb signaling pathway 0.5099837448204362 1.022253778203625 0.3066608036641058 1.0 0.9035274410396096 17 P22681,P45985,P31751,P28482,Q13555,P16333 6 |
| Dual hijack model of vif in hiv infection 0.854580474685253 1.018033590745287 0.3086619929715277 1.0 0.9050089502660328 4 Q13951,Q15370 2 |
| Egfr tyrosine kinase inhibitor resistance 0.5070356576158731 1.009013388642571 0.3129682132227245 1.0 0.9088115422429116 17 Q07812,P31751,P28482,P06730,P62753,P40763 6 |
| Insulin signaling in adipocytes diabetic condition 0.6460077376225501 1.0000916087671563 0.3172661766140503 1.0 0.9125179555946972 5 P31751 1 |
| Insulin signaling in adipocytes normal condition 0.6460077376225501 1.0000916087671563 0.3172661766140503 1.0 0.9125179555946972 5 P31751 1 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.4825346048315259 0.9913639803550386 0.3215078818778698 1.0 0.918733923280358 13 P22681,P11802,O14920,Q9UHD1,P16333 5 |
| Heart development 0.8430458010426919 0.9788405092922156 0.3276587904510317 1.0 0.9204926020112706 4 P28482,Q12948 2 |
| G protein signaling pathways 0.4892487394030954 0.9750187701872728 0.3295509493300019 1.0 0.9215220990524128 15 O43823,P61586,Q08209,P08754,Q92667,Q92888 6 |
| Photodynamic therapyinduced hif1 survival signaling 0.4650270970919312 0.958696970963478 0.3377114248582065 1.0 0.931405025636332 11 Q07812,P17858,P14618,P00558,P00338 5 |
| Regulatory circuits of the stat3 signaling pathway 0.4582006193660948 0.951212361629904 0.3414965844782027 1.0 0.9357801732395652 10 P28482,Q96B36 2 |
| Nitric oxide metabolism in cystic fibrosis 0.8256730137885707 0.9202610758526324 0.3574363445258983 1.0 0.9409075077802226 4 Q99873,O60678,Q86X55 3 |
| Ras and bradykinin pathways in covid19 0.8565802428618364 0.9156502090455652 0.3598503879093235 1.0 0.9409075077802226 3 P28482,P61586 2 |
| Oxidative damage response 0.4282913578666499 0.909310458276021 0.3631862716843397 1.0 0.9414785755250694 6 P45985,O95429 2 |
| Congenital generalized lipodystrophy cgl 0.8225065616797742 0.8828963070391487 0.377292299096708 1.0 0.9445985562667416 2 P31751 1 |
| Fibrin complement receptor 3 signaling pathway 0.6144248976330653 0.8771374541601884 0.3804119833083956 1.0 0.9445985562667416 5 O14920 1 |
| Thermogenesis 0.5101262210044689 0.8702895954750803 0.3841421634431254 1.0 0.9445985562667416 24 O43772,Q96B36,O14497,P49815,P62753 5 |
| Mirnas involvement in the immune response in sepsis 0.8107005214421426 0.8702850022014034 0.384144672988586 1.0 0.9445985562667416 4 Q15750 1 |
| Angiotensin ii receptor type 1 pathway 0.8405231750010405 0.8586021076682485 0.3905600748908036 1.0 0.9445985562667416 3 P28482 1 |
| Pancreatic adenocarcinoma pathway 0.5024015328994024 0.8578706365480138 0.3909638998625198 1.0 0.9445985562667416 23 P11233,Q07812,P11802,O14920,P61586,P31751,P28482,P40763 8 |
| Cell migration and invasion through p75ntr 0.4167534689102367 0.8551449586893723 0.3924709028677848 1.0 0.9445985562667416 6 P31751,P61586 2 |
| Translation factors 0.5613731183097809 0.8316586961644732 0.4056016208322126 1.0 0.9446849877216804 37 P24534,O75153,Q13347,Q9NR50,P13639,P05198,P19525,O43432,P63241,O75822,Q05639,Q9UI10,P60228,P06730,P11940,P60842,P55010,P55884,O15371 19 |
| Glioblastoma signaling pathways 0.4800734341439378 0.8242798341405451 0.4097805741441727 1.0 0.9446849877216804 20 P22681,P49815,P11802,P45985,P31751,P28482 6 |
| Nanoparticlemediated activation of receptor signaling 0.4192553601378872 0.8190837313774634 0.4127386431182236 1.0 0.9473816223362868 8 P28482 1 |
| Tolllike receptor signaling pathway 0.4478489514215447 0.8120230805457063 0.4167783878542574 1.0 0.9473816223362868 14 Q15750,P28482,P31751 3 |
| Dna damage response only atm dependent 0.4618281473246589 0.8085172680325869 0.4187928694764711 1.0 0.9473816223362868 17 Q07812,P61586,P28482,P31751,P35222 5 |
| Netrinunc5b signaling pathway 0.4418985947568984 0.7856985957924517 0.4320440860861843 1.0 0.9700915538886814 14 P61586,P28482,Q8TCG1,Q15257,P30154 5 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4106159182523923 0.7795231530087156 0.4356716043008288 1.0 0.9716828850881218 8 P06730,Q96B36 2 |
| Hypertrophy model 0.8100207084828236 0.7526195368432469 0.4516785741419102 1.0 0.9789842833247072 3 P20248 1 |
| Gdnfret signaling axis 0.7744458995594222 0.7517308422388037 0.4522129388205187 1.0 0.9789842833247072 4 Q12948,P35222 2 |
| Pentose phosphate metabolism 0.5799393662076718 0.7460556840709535 0.4556337781268735 1.0 0.9790083091655496 5 P29401,P52209,O95336 3 |
| Glycolysis and gluconeogenesis 0.4922125170736839 0.7364345389174521 0.4614662916783414 1.0 0.9802713442477275 27 Q01813,P18669,P09972,P07195,P04075,P60174,P11498,P40925,P08237,P17858,P14618,P00558,P09104,P08559,P00338 15 |
| Neural crest cell migration during development 0.3957393472063399 0.7346621888141974 0.4625452534943748 1.0 0.9802713442477275 7 P61586,P31751 2 |
| Endoplasmic reticulum stress response in coronavirus infection 0.3945538013771185 0.7292803467785084 0.4658301916322629 1.0 0.9804921028746952 7 P05198,P62136 2 |
| Airway smooth muscle cell contraction 0.7668728656591723 0.7274911697569101 0.4669251227202835 1.0 0.9804921028746952 4 P61586 1 |
| Leukocyteintrinsic hippo pathway functions 0.5746978448168399 0.7265210411120597 0.4675194132912454 1.0 0.9804921028746952 5 Q13043,P61586 2 |
| Photodynamic therapyinduced unfolded protein response 0.4024042819475732 0.7198954163349944 0.4715893904090213 1.0 0.9856055079828682 9 Q13217,O43776,P05198 3 |
| Interleukin11 signaling pathway 0.4189768318308683 0.7066943516766648 0.4797564404133683 1.0 0.9957831271810118 13 O14920,Q15257,P28482,P62753,P40763 5 |
| 1q211 copy number variation syndrome 0.3977361977803083 0.6775289350362715 0.4980704178873951 1.0 1.0 10 Q96J84,P35222 2 |
| Wnt signaling pathway and pluripotency 0.4257469224682093 0.6740996449501175 0.5002479652309302 1.0 1.0 16 P63151,P45985,P61586,Q15257,P35222,P30154 6 |
| Modulators of tcr signaling and t cell activation 0.4157895243115542 0.672234612556642 0.5014343491989097 1.0 1.0 14 O14920,O95376,Q15366,Q15370 4 |
| Pdgf pathway 0.4153726882572739 0.6704547659048097 0.5025679327952863 1.0 1.0 14 P28482,P45985,P40763,P61586 4 |
| Gaba receptor signaling 0.3813600562414938 0.6699192243544059 0.5029092839802358 1.0 1.0 7 Q96CW1 1 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.7458399240326998 0.6613067155492492 0.5084156356327045 1.0 1.0 4 P28482 1 |
| Hippo signaling regulation pathways 0.4231728359564098 0.6435882682938073 0.5198424597547355 1.0 1.0 17 P08754,P35222 2 |
| Breast cancer pathway 0.4488197447739515 0.6351830458711553 0.5253090394001374 1.0 1.0 23 Q07812,P11802,P31751,P63208,P28482,P48729,P35222 7 |
| Dna mismatch repair 0.4294540477010636 0.6311364512235336 0.5279513091583474 1.0 1.0 19 P15927,Q9UQ84,P18858,P12004,P40938,Q9NRF9,Q07864,P27694,P35249,P35250,P28340,P52701 12 |
| Mirna biogenesis 0.7314510833880508 0.617106763009135 0.5371643081577715 1.0 1.0 4 Q9UPY3,Q8WYQ5,Q9HAV4 3 |
| Lncrna in canonical wnt signaling and colorectal cancer 0.3882923990364942 0.6159267847100897 0.5379428427866448 1.0 1.0 11 P48729,P35222,P19784,Q13363,Q9Y265,P61978 6 |
| Cori cycle 0.3973598688374204 0.614248923877225 0.5390508484597853 1.0 1.0 13 P04075,Q01813,P18669,P60174,P11413,P00558,P04406,P00338 8 |
| Clear cell renal cell carcinoma pathways 0.5181809407533059 0.6001002131953485 0.5484394505036514 1.0 1.0 41 P09972,O00763,P78330,P09104,P40763,P49815,P60174,P17858,P08237,Q9Y617,P04075,P07195,Q96B36,O43175,Q13085,P53396,Q13501,P00338,P00558,P34896 20 |
| Rac1pak1p38mmp2 pathway 0.4247128715156352 0.5934761082518301 0.5528625676122263 1.0 1.0 20 Q07812,O14920,P28482,P35222,P16333,P40763 6 |
| Tgfbeta signaling pathway 0.4787804722874788 0.5801463188058832 0.5618159504507418 1.0 1.0 33 Q96J02,O95067,Q7Z3T8,P45985,Q9Y3F4,P61586,Q15750,P63208,P28482,Q96PU5 10 |
| Regulation of actin cytoskeleton 0.4903194514157102 0.5754954445446737 0.5649562706733251 1.0 1.0 36 O15511,Q9UQB8,Q8N8S7,P61586,P28482,Q92888 6 |
| Mitochondrial gene expression 0.5256738124321885 0.550669874233053 0.5818599997362677 1.0 1.0 5 Q08209 1 |
| Exrna mechanism of action and biogenesis 0.7466360354446999 0.5460331411542887 0.5850431564233682 1.0 1.0 3 Q9UPY3,Q9HAV4 2 |
| Ras signaling 0.4651097332557002 0.5457628256445305 0.5852289797141386 1.0 1.0 32 P11233,P62330,O14920,P31751,P28482,P61020,Q9UQ13 7 |
| Pi3kaktmtor vitd3 signaling 0.5212181940657806 0.5354279505328478 0.5923539668437947 1.0 1.0 5 P49815 1 |
| Metabolic reprogramming in colon cancer 0.4853063687896471 0.5278826518639891 0.5975807862163147 1.0 1.0 38 P22234,P78330,P06733,P48735,Q06203,P11413,P49327,P00367,P17858,P14618,Q99798,Q9Y617,P18669,P52209,P53396,P04406,P29401,O94925,P08559,P11177,P00338,P34897,P00558 23 |
| Dna damage response 0.4251329381014204 0.5259706869006506 0.5989085739108799 1.0 1.0 24 O95067,Q00535,P11802,P78527,Q86UE8 5 |
| Chemokine signaling pathway 0.4181096034657044 0.516082815503956 0.6057965695664667 1.0 1.0 23 O14920,P31751,P28482,P08754,P40763 5 |
| Thymic stromal lymphopoietin tslp signaling pathway 0.3638559212115516 0.5144248029732109 0.6069550219169477 1.0 1.0 11 P28482,P62753 2 |
| Prostaglandin and leukotriene metabolism in senescence 0.7360842163309493 0.5139379857386391 0.6072953486552752 1.0 1.0 3 P09960 1 |
| Androgen receptor signaling pathway 0.4343720953611719 0.5119525004352742 0.6086842534022019 1.0 1.0 27 Q9UBS8,Q86X55,P61586,P60981,P35222,Q96EB6,P40763,P63244 8 |
| Vasopressinregulated water reabsorption 0.3739944090100566 0.5004559094564635 0.6167540942257765 1.0 1.0 14 P51148,Q14204,P52565,P46459,P63167,P61020 6 |
| Acetylcholine synthesis 0.7185039370078754 0.49925131048748 0.6176023513234068 1.0 1.0 2 P35790 1 |
| Agerage pathway 0.3900147444174371 0.4766688180375471 0.6335979704748382 1.0 1.0 19 P28482,O14920,P61586 3 |
| Met in type 1 papillary renal cell carcinoma 0.3940995610380968 0.475585906243107 0.6343694180943775 1.0 1.0 20 P22681,O43815,P31751,P28482,P40763,P62993 6 |
| Nad biosynthetic pathways 0.721926859012814 0.4721117239357253 0.6368470446098031 1.0 1.0 3 P43490 1 |
| Nad metabolism 0.721926859012814 0.4721117239357253 0.6368470446098031 1.0 1.0 3 P43490 1 |
| Melanoma 0.3663831994349268 0.4709321899415876 0.6376891598279808 1.0 1.0 14 P11802,P28482,Q07812,P31751 4 |
| Exerciseinduced circadian regulation 0.3662407626715578 0.4703858098137071 0.6380794004892576 1.0 1.0 14 Q96PU8,P21266 2 |
| Leptin signaling pathway 0.4225860967472757 0.454963748315748 0.6491353193966072 1.0 1.0 28 O00763,Q07812,Q13085,O14920,P61586,P06730,P28482,P62753,P40763 9 |
| Mirna regulation of dna damage response 0.4090745132542089 0.4519879249959344 0.6512776813435259 1.0 1.0 25 O95067,Q00535,P11802,P78527,Q86UE8 5 |
| Nicotine effect on dopaminergic neurons 0.6716085556456861 0.4450602653452988 0.6562762028069722 1.0 1.0 4 Q00535 1 |
| Nad metabolism sirtuins and aging 0.6647607411716514 0.4268046590388675 0.6695216127375443 1.0 1.0 4 P43490 1 |
| Nrp1triggered signaling pathways in pancreatic cancer 0.3545733903070481 0.42644501759072 0.6697836041756864 1.0 1.0 14 P31751 1 |
| Gaba metabolism aka ghb 0.6948818897637679 0.4239024533330341 0.6716369548868406 1.0 1.0 2 O43488 1 |
| Epithelial to mesenchymal transition in colorectal cancer 0.3744484141503132 0.4200594769263249 0.6744420048370723 1.0 1.0 19 P45985,Q9Y3F4,P31751,P28482,P35222,O75340 6 |
| Chromosomal and microsatellite instability in colorectal cancer 0.381040002920072 0.4133083541389593 0.6793807099067972 1.0 1.0 21 P11233,P61586,P31751,P28482,P48729,P35222 6 |
| Prion disease pathway 0.3289345287705646 0.4128497898639233 0.6797166698538182 1.0 1.0 9 P28482 1 |
| Tcell receptor tcr signaling pathway 0.3639230825612558 0.3834819694333058 0.7013624366555751 1.0 1.0 19 P16333,P28482,O14920,P22681 4 |
| Oncostatin m signaling pathway 0.3542160073026917 0.379130598472053 0.704590885186934 1.0 1.0 17 P28482,P40763,P62753,P20248 4 |
| Cellular proteostasis 0.6872333442730499 0.3762893397521876 0.7067018035876642 1.0 1.0 3 P61758,Q9UHV9 2 |
| Homologous recombination 0.3097512409670126 0.3739308179558016 0.7084557875104742 1.0 1.0 7 P28340 1 |
| Neuroinflammation and glutamatergic signaling 0.3810486023896617 0.3713861341803729 0.7103499516125535 1.0 1.0 24 O43175,P78330,P28482,P34896,P23528,Q13555,P40763,Q9Y617,P62136 9 |
| Erk pathway in huntingtons disease 0.6429277781206996 0.3709000595027885 0.7107119708343776 1.0 1.0 4 P28482 1 |
| Acute viral myocarditis 0.3443149782502358 0.3597357883620588 0.7190447260256692 1.0 1.0 16 P28482,Q13418,Q07812,O00273 4 |
| Retinoblastoma gene in cancer 0.4537302141984912 0.3542678058378387 0.723138192425512 1.0 1.0 44 O95067,P00374,P11802,O95239,P78527,P27694,P20248,P23921 8 |
| Proteasome degradation 0.4392612335516866 0.3453415663156199 0.7298376011642291 1.0 1.0 41 P60900,P25788,O75832,P28072,P20618,P28070,P49721,Q15008,P25786,Q99460,P51665,P28074,Q9UNM6,P25787,P35998,P43686,P62195,P22314,O00232,P62191,P49720,P25789 22 |
| Base excision repair 0.3440709763273973 0.3449851449458265 0.7301055385788207 1.0 1.0 17 Q9NRF9,P27695,P18887 3 |
| Regucalcin in proximal tubule epithelial kidney cells 0.2994929566329565 0.336761727752238 0.7362965263354444 1.0 1.0 7 P28482 1 |
| Alzheimers disease 0.5695334311097615 0.330191997449369 0.741254893182828 1.0 1.0 81 P07437,P68371,P04350,Q9BVA1,P49720,Q13885,P49721,Q9BUF5,Q00535,P31751,P28482,Q08209,Q9Y4P8,P07384,P20618,P28070 16 |
| Translation inhibitors in chronically activated pdgfra cells 0.3430867355971729 0.3284388189963284 0.742579896037018 1.0 1.0 18 P28482,P62753,P06730,P31751 4 |
| Glycogen synthesis and degradation 0.3328866664039379 0.3220569555209599 0.7474095468580726 1.0 1.0 16 P63151,P35573,Q15257 3 |
| Alzheimers disease and mirna effects 0.5653617624457278 0.3150848945923662 0.7526971971978489 1.0 1.0 82 P07437,P68371,P04350,Q9BVA1,P49720,Q13885,P49721,Q9BUF5,Q00535,P31751,P28482,Q08209,Q9Y4P8,P07384,P20618,P28070 16 |
| Caloric restriction and aging 0.4469593869480481 0.3071076686698333 0.7587614208312208 1.0 1.0 5 P43490 1 |
| Interleukin1 induced activation of nfkb 0.6535433070866193 0.3065675566398795 0.7591725512796843 1.0 1.0 2 Q13501 1 |
| Synaptic vesicle pathway 0.3186733426278051 0.3028881936131681 0.7619750691243539 1.0 1.0 14 Q96CW1,P09496,Q99497,Q00610,O94973,O00429 6 |
| Small cell lung cancer 0.3202136593858714 0.294971889478316 0.7680153537357568 1.0 1.0 15 P11802,O14920,P63208,P31751 4 |
| Alpha 6 beta 4 signaling pathway 0.3068838825807616 0.2914575866867656 0.7707013773480593 1.0 1.0 12 P28482,P61586 2 |
| Camkk2 pathway 0.2942042540036492 0.2772235238782178 0.7816084777877426 1.0 1.0 10 P28482,Q13501 2 |
| Methylation pathways 0.6400545282596369 0.2635807376029351 0.7921030029384872 1.0 1.0 3 Q9NZL9 1 |
| Cohesin complex cornelia de lange syndrome 0.3159125924696554 0.2586369675002011 0.795915357528167 1.0 1.0 17 Q9Y6X3 1 |
| Tca cycle in senescence 0.2731964145754818 0.2497630093738746 0.8027706275000126 1.0 1.0 7 P08559,P48163 2 |
| Pilocytic astrocytoma 0.6330817197243215 0.2488301314209179 0.8034921824991759 1.0 1.0 3 P21359,P62993 2 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.300525194948509 0.2483213832479967 0.8038857556030188 1.0 1.0 14 P11802,P48729,P35222,P42166 4 |
| Apoptosis 0.3076924492891585 0.2465225786527163 0.8052777284190482 1.0 1.0 16 O14920,Q07812,O00273 3 |
| Influence of laminopathies on wnt signaling 0.2830861792770571 0.2435009937681943 0.8076173153580977 1.0 1.0 10 Q5JTV8,P48729,P35222 3 |
| Mitochondrial complex i assembly model oxphos system 0.3387936340823267 0.238278811153616 0.8116648543671694 1.0 1.0 25 O95169,O75306,O75438,P03886,P49821,O95299,Q7L592 7 |
| Ncrnas involved in wnt signaling in hepatocellular carcinoma 0.2758733953604383 0.2340123607659436 0.8149753825645547 1.0 1.0 9 P48729,P35222 2 |
| G13 signaling pathway 0.2978865793417229 0.2302656475262368 0.8178853527092866 1.0 1.0 15 Q92888,P61586 2 |
| Nrf2 pathway 0.3242321874356562 0.2298056698429769 0.8182427787317421 1.0 1.0 22 P30041,Q14914,P52209,Q13501,O15217,P21266 6 |
| Fragile x syndrome 0.3928816270351389 0.2239465081519108 0.8227989263591708 1.0 1.0 42 Q96B36,P49815,Q96CW1,P09496,P06730,P28482,Q08209,P46821,Q9Y4R8,Q06787,Q9NQX3 11 |
| Mammary gland development pathway involution stage 4 of 4 0.6199313316614112 0.2224229804355457 0.8239846240290025 1.0 1.0 3 Q07812 1 |
| Glucuronidation 0.4109716795934508 0.2185635647231066 0.826990037694133 1.0 1.0 5 Q96G03,P36871,O95394 3 |
| Hepatitis b infection 0.3305842818552617 0.218323078792209 0.8271773938703886 1.0 1.0 25 Q07812,Q16531,P45985,O14920,P31751,Q15750,P28482,P40763,P62993,O00571 10 |
| Dna irdouble strand breaks and cellular response via atm 0.3264817068934085 0.2172471501607255 0.8280157414893821 1.0 1.0 24 Q9UQ84,O96017,Q00535,Q07812,Q92900,P78527,O96019 7 |
| Vegfavegfr2 signaling pathway 0.3162832569472376 0.2166010818500695 0.8285192425592263 1.0 1.0 176 Q96J02,P47756,O00763,Q12800,P48735,O15355,Q08209,P35222,P62906,P16333,Q16527,P07737,P40763,P62280,P05198,P62993,O00299,P62330,P07814,Q7Z478,Q92783,Q9Y613,P61586,Q13045,P62753,P24666,Q9Y520,P63244,P11171,P04075,Q96B36,P18085,Q13085,Q15369,P52209,P06730,Q9UG63,P00338,P22681,P30041,Q9UNL2,Q01844,P45985,Q96PU8,O15371,P28482,Q6Y7W6,P20248,P00558,Q8WU90 50 |
| Apoptosis modulation and signaling 0.2985742545139388 0.2123193809565838 0.8318578762839919 1.0 1.0 17 O14920,P04632,O00273,O95831 4 |
| B cell receptor signaling pathway 0.3088388985407109 0.2101545442897104 0.8335470556853133 1.0 1.0 20 P16333,O14920,P28482 3 |
| Transcription factors regulate mirnas related to cardiac hypertrophy 0.5668563192183902 0.207758946709556 0.8354171889057749 1.0 1.0 4 P31751 1 |
| Thyroid stimulating hormone tsh signaling pathway 0.2978199749772028 0.2013584169421001 0.8404183277121868 1.0 1.0 18 P11802,P28482,P62753,P08754,P27695 5 |
| Gastrin signaling pathway 0.3267143842787274 0.2012737704050772 0.840484511051593 1.0 1.0 26 O14920,P61586,P28482,P62753,P35222,P40763 6 |
| Complement system 0.2766814259639975 0.194958559382696 0.8454253898744257 1.0 1.0 13 P08754,P48729,P15529,Q99829 4 |
| Kallmann syndrome 0.5585127865612484 0.1931916651508634 0.8468088660250217 1.0 1.0 4 P28482 1 |
| Tnfalpha signaling pathway 0.3093358338444573 0.1791506916461173 0.8578193796218567 1.0 1.0 24 Q07812,P45985,O14920,Q15750,P63208,P28482 6 |
| Hippoyap signaling pathway 0.5898950131233641 0.1679867611533567 0.8665936941425694 1.0 1.0 2 Q13043 1 |
| Network map of sarscov2 signaling pathway 0.3097452811514963 0.1663795929203378 0.8678582326056701 1.0 1.0 26 Q96J02,O95067,Q96B36,P06730,P62753,Q99829,P31350 7 |
| Praderwilli and angelman syndrome 0.3827922791876897 0.1614200047923358 0.8717626117336608 1.0 1.0 5 P11802 1 |
| Tgfbeta receptor signaling 0.3818038650502008 0.1596191962584875 0.8731810564400371 1.0 1.0 5 P35222 1 |
| Tgfbeta receptor signaling in skeletal dysplasias 0.3818038650502008 0.1596191962584875 0.8731810564400371 1.0 1.0 5 P35222 1 |
| Tumor suppressor activity of smarcb1 0.2566044615533148 0.1566951228252282 0.8754851310197962 1.0 1.0 12 P11802,O14497,Q96GM5 3 |
| Integrinmediated cell adhesion 0.2926304677371555 0.1531127272627834 0.878309379319554 1.0 1.0 23 Q13418,P31751,P28482,P07384,P04632 5 |
| Pentose phosphate pathway in senescent cells 0.3772287111010633 0.1514652407304244 0.8796087283358236 1.0 1.0 5 P11413,P29401,O95336 3 |
| Nocgmppkg mediated neuroprotection 0.529305049573977 0.1476894976672321 0.8825878203867934 1.0 1.0 4 Q15334,Q13555 2 |
| Insulin signaling 0.3412401919604806 0.1416367788351199 0.8873669144684466 1.0 1.0 41 P22681,P49815,O00186,Q6ZWJ1,P62330,P45985,P17858,O14920,P31751,P06730,P28482,P62993 12 |
| Myometrial relaxation and contraction pathways 0.2604065028880022 0.1366844058513514 0.8912802561631601 1.0 1.0 16 Q99439 1 |
| Nanoparticle triggered regulated necrosis 0.5702099737532886 0.1361350365441997 0.8917145301908127 1.0 1.0 2 Q13546 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.2459969763231528 0.1348778553975567 0.8927084483741712 1.0 1.0 12 P13674,Q5JRA6 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.2610238187911072 0.1318085393634654 0.8951357320524329 1.0 1.0 17 Q15149,P42166,P61586,P28482,P62993 5 |
| Hif1a and pparg regulation of glycolysis 0.517220494020922 0.1313648360565684 0.8954867043241759 1.0 1.0 4 P00338 1 |
| Brainderived neurotrophic factor bdnf signaling pathway 0.3317821892137911 0.1264741935568964 0.8993565755521113 1.0 1.0 42 P49815,O00763,Q00535,O14920,P06730,P28482,P35222,P16333,P63244 9 |
| Prolactin signaling pathway 0.2728092049400801 0.1248000197980413 0.9006818717186882 1.0 1.0 22 P22681,P28482,P62753,P40763,P62993 5 |
| Circadian rhythm genes 0.3113521921304454 0.1213701967901489 0.9033978218578352 1.0 1.0 36 P17844,Q9BWF3,P11802,Q14103,Q13616,P23526,P78527,P63208,O14744,Q96EB6,P43490,Q9NRV9,P62136 13 |
| Ciliary landscape 0.179150235538682 0.1206901242876714 0.903936481490558 1.0 1.0 93 P17844,Q9BW83,Q8TD19,O15173,P63167,P35222,Q5SW79,Q9NVJ2,Q15555,P51665,P33993,Q7L590,P43686,P61962,P60660,Q12904,O95400,Q92905,Q9NQH7,Q9UNS2,P31150,Q14204,Q9Y312,A0AVF1,Q9UN37 25 |
| Pathways affected in adenoid cystic carcinoma 0.2510254329463242 0.1201860370288114 0.9043357784331136 1.0 1.0 16 P10412,O14497,O96017,P78527,Q96T88 5 |
| Focal adhesion pi3kaktmtorsignaling pathway 0.3157860499238404 0.1121444096994501 0.91070890564071 1.0 1.0 41 Q96B36,P49815,Q13085,O14920,P31751,P06730,P28482 7 |
| T cell receptor and costimulatory signaling 0.5002186908206696 0.1108370634439362 0.9117455540319028 1.0 1.0 4 Q08209 1 |
| Transcription cofactors ski and skil protein partners 0.3492126836211186 0.1080286223242932 0.91397298773459 1.0 1.0 5 P21359,O14744 2 |
| Atr signaling 0.5415162454873784 0.1041371503633148 0.9170605093914042 1.0 1.0 3 O14757,P27694 2 |
| Pi3kakt signaling pathway 0.3011904590442194 0.1008984404571726 0.919631081126294 1.0 1.0 40 P49815,P11802,P63151,O14920,P31751,P06730,P28482,P62753 8 |
| Cytoplasmic ribosomal proteins 0.2176682622400322 0.0990105990344043 0.9211298546448496 1.0 1.0 74 P32969,P62241,P08708,P62906,P62701,P62829,P62280,P25398,P60866,P18124,P61927,P62266,P30050,P15880,P83881,P36578,P83731,P63173,P18077,P62851,P62753,P61313,P62249,P84098,Q9Y3U8,P26373,P62841,P23396,P27635,P46781,P63220,P46778,P08865,P18621,P35268,P05388 36 |
| Egfegfr signaling pathway 0.3029007206592525 0.0989213576432113 0.9212007111284344 1.0 1.0 42 Q96J02,Q96CW1,P62330,P28482,P16333,Q92888 6 |
| Mbdnf and probdnf regulation of gaba neurotransmission 0.3393245788069884 0.0953194999809992 0.9240610544287468 1.0 1.0 5 P40763,P61586 2 |
| Measles virus infection 0.2580597247321892 0.09389854481232 0.9251897498032556 1.0 1.0 25 Q07812,P11802,O14920,Q7Z434,P19525,P42224,P19784,P15529,P63244,P40763,P49327,P05198,O15372,P24941 14 |
| Amino acid metabolism 0.2995639554770075 0.089547199476432 0.9286470444607432 1.0 1.0 52 O75874,P54136,Q9NSD9,P00367,P08243,P07814,P14618,P54687,P11498,P25325,P53396,P52788,P08559,Q96RQ3,P00338,P09110,P26640,P41252,Q6NVY1 19 |
| Wntbetacatenin signaling pathway in leukemia 0.3277056313449973 0.0820661559720305 0.9345941059358336 1.0 1.0 5 P35222 1 |
| 7q1123 copy number variation syndrome 0.2679262652825467 0.0782002500174316 0.9376687631431062 1.0 1.0 45 O00763,O75533,Q13085,Q99816,Q9H9H4,Q5TC12 6 |
| Urea cycle and associated pathways 0.209677419354842 0.0780947809580455 0.9377526587091314 1.0 1.0 12 P07195,P00505,P40925,O75746,P00367,Q9Y619,P40926,P04181,P32322,P07954,P17174 11 |
| Dna replication 0.2496407658485351 0.077957646063587 0.93786174395776 1.0 1.0 29 P35250,P15927,P12004,P33992,P40938,P41440,Q9UBD5,Q07864,P27694,P35249,O43913,P33993,P28340,Q7L590,P24941 15 |
| Pyrimidine metabolism 0.2573520271483283 0.0744910857763462 0.9406196339815008 1.0 1.0 40 Q9NRF8,P23921,P04183,P22392,P17812,P62487,O14802,Q9NRF9,Q07864,P31350,P28340,P11172 12 |
| Endoderm differentiation 0.2410005503218831 0.0731554007834571 0.9416824562648716 1.0 1.0 28 Q6P1J9,Q8IWS0,Q07021,Q13085,Q6PD62,O95071,P35222,Q9Y2X9 8 |
| Cell cycle 0.2381015214463092 0.0715369313851868 0.942970432841477 1.0 1.0 46 O95067,O96017,P12004,P11802,Q9UBD5,P78527,P63208,P20248,P33993,O43684,Q13616 11 |
| Dna repair pathways full network 0.1963979528954334 0.0709995818535023 0.9433980882850328 1.0 1.0 49 Q9UQ84,P18887,P27695,P78527,Q9NRF9,P28340 6 |
| Mitochondrial fatty acid synthesis pathway 0.5005027444113553 0.0675610415858784 0.9461350688161024 1.0 1.0 3 Q13085 1 |
| Heme biosynthesis 0.4508684203585684 0.0664321198145984 0.9470337987616342 1.0 1.0 4 P06132 1 |
| Focal adhesion 0.2240944320685388 0.0637772026973971 0.9491476309073597 1.0 1.0 37 P31751,P28482,P61586,P35222,Q13418,P62993 6 |
| Alanine and aspartate metabolism 0.4421610967096497 0.0607293091967705 0.9515747893897571 1.0 1.0 4 P11498 1 |
| Nucleotide excision repair in xeroderma pigmentosum 0.2026110120439344 0.0578937658938681 0.9538332488911948 1.0 1.0 34 P18887,Q16531,Q86WJ1,Q9NRF9,Q07864,P27694,P28340 7 |
| Dna irdamage and cellular response via atr 0.1878168518485732 0.0576108510772743 0.954058606120815 1.0 1.0 36 Q9UQ84,O96017,P12004,O95714,O43324,Q92900,P78527,P27694,P33993 9 |
| 22q112 copy number variation syndrome 0.1907957762305962 0.0533520104026135 0.9574514408677844 1.0 1.0 30 Q9UQ13 1 |
| G1 to s cell cycle control 0.19074443054006 0.0506759588554839 0.9595837340827376 1.0 1.0 22 P12004,P11802,Q9UBD5,Q07864,P27694,P33993 6 |
| Nucleotide excision repair 0.1893392149483 0.0504029189919624 0.9598013103257228 1.0 1.0 24 P15927,P18858,P12004,Q16531,P40938,Q9NRF9,P19447,Q07864,P27694,P35249,P35250,P28340 12 |
| 16p112 proximal deletion syndrome 0.1846037537346651 0.0490863802846437 0.9608504572820582 1.0 1.0 24 P04075,P48643,P12004,P49368,P40227,P50990,P17987,Q99832,P78318 9 |
| Leptininsulin signaling overlap 0.4145603691510534 0.0319223471893447 0.9745339772398608 1.0 1.0 3 P40763 1 |
| Vitamin b12 disorders 0.3649470379927036 0.0312239875087179 0.9750909099730704 1.0 1.0 4 Q9NPF0 1 |
| Unfolded protein response 0.3416462901650718 0.0276000303280371 0.9779811574774436 1.0 1.0 4 P05198 1 |
|
|
